XML 62 R52.htm IDEA: XBRL DOCUMENT v3.25.2
Note 7 - Fair Value of Financial Instruments (Details Textual)
€ in Thousands, $ in Millions
3 Months Ended 6 Months Ended
Mar. 16, 2022
Mar. 16, 2022
EUR (€)
Dec. 22, 2021
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2025
USD ($)
Jul. 24, 2024
USD ($)
Jul. 15, 2024
USD ($)
Jun. 24, 2024
USD ($)
Payment for Contingent Consideration Liability       $ 5.0 $ 5.3      
Present Value of Non-competition Agreement       5.1 5.1      
Welch Fluorocarbon, Inc [Member]                
Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount             $ 6.0  
Business Combination, Contingent Consideration, Liability       0.8 0.8   $ 0.8  
Marble Medical, Inc [Member]                
Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount           $ 0.5    
Business Combination, Contingent Consideration, Liability       0.4 0.4     $ 0.4
DAS Medical [Member]                
Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount     $ 20.0          
Business Combination, Contingent Consideration, Liability       5.2 5.2      
DAS Medical [Member] | Non-Competition Agreements [Member]                
Payments to Acquire Businesses, Gross     $ 10.0 0.1 1.8      
Business Combination, Agreement Term     10 years          
Marble Medical and DAS Medical [Member]                
Business Combination, Contingent Consideration, Liability       $ 5.5 5.5      
Business Combination, Consideration Transferred, Liabilities Incurred         $ 9.3      
Advant Medical [Member] | Non-Competition Agreements [Member]                
Payments to Acquire Businesses, Gross | €   € 375            
Business Combination, Agreement Term 3 years